Full Text View
Tabular View
No Study Results Posted
Related Studies
Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
This study has been completed.
Study NCT00002985   Information provided by Roswell Park Cancer Institute

First Received on November 1, 1999.   Last Updated on February 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sarcoma
Additional conditions recognized in this trial
AIDS-Related Opportunistic Infections
Sarcoma, Kaposi
More general conditions related to this trial
DNA Virus Infections
Herpesviridae Infections
HIV Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Infection
Lentivirus Infections
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Neoplasms, Vascular Tissue
Opportunistic Infections
Parasitic Diseases
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
daunorubicin hydrochloride
Additional drug interventions recognized in this trial
Daunorubicin
Doxorubicin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Roswell Park Cancer Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services